Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q2 2023 · 10-Q
Revenue$36.52M$36.52M+10.7% vs Q2 2022 Net Income-$958.00K-$958.00KN/M vs Q2 2022 EPS Diluted$0.00$0.00— vs Q2 2022 Gross Profit$16,376,000+9.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Operating Cash Flowderived$1,275,000N/M Free Cash Flowderived-$4,459,000N/M Margins · derivedGross margin44.8%−0.6 pt vs Q2 2022
Operating margin9.7%−3.9 pt vs Q2 2022
Net margin-2.6%−8.1 pt vs Q2 2022
ended Jun 30, 2023 · filed Aug 4, 2023 · 35 d after period end